JPS604187B2 - ４−アミノキノリン誘導体の製造方法 - Google Patents

４−アミノキノリン誘導体の製造方法

Info

Publication number
JPS604187B2
JPS604187B2 JP48027544A JP2754473A JPS604187B2 JP S604187 B2 JPS604187 B2 JP S604187B2 JP 48027544 A JP48027544 A JP 48027544A JP 2754473 A JP2754473 A JP 2754473A JP S604187 B2 JPS604187 B2 JP S604187B2
Authority
JP
Japan
Prior art keywords
group
formula
lower alkyl
amino
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48027544A
Other languages
English (en)
Japanese (ja)
Other versions
JPS49273A (en:Method
Inventor
ルフアツプ ア−キボ−ルド ジヨン
ク−ランス ア−ノツト ボイル ジヨン
クリストフア− サウンダ−ズ ジヨン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JON UIISU ANDO BURAZAA Ltd
Original Assignee
JON UIISU ANDO BURAZAA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JON UIISU ANDO BURAZAA Ltd filed Critical JON UIISU ANDO BURAZAA Ltd
Publication of JPS49273A publication Critical patent/JPS49273A/ja
Publication of JPS604187B2 publication Critical patent/JPS604187B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP48027544A 1972-03-10 1973-03-08 ４−アミノキノリン誘導体の製造方法 Expired JPS604187B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB1125172 1972-03-10
GB11251/72 1972-03-10
GB30635/72 1972-06-30
GB3063572 1972-06-30
GB4859372 1972-10-21
GB48593/72 1972-10-21
GB553173A GB1416872A (en) 1972-03-10 1973-02-05 4-aminoquinoline derivatives
GB5531/73 1973-02-05

Publications (2)

Publication Number Publication Date
JPS49273A JPS49273A (en:Method) 1974-01-05
JPS604187B2 true JPS604187B2 (ja) 1985-02-01

Family

ID=27447454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48027544A Expired JPS604187B2 (ja) 1972-03-10 1973-03-08 ４−アミノキノリン誘導体の製造方法

Country Status (10)

Country Link
JP (1) JPS604187B2 (en:Method)
AU (1) AU467944B2 (en:Method)
BE (1) BE855713Q (en:Method)
CH (2) CH576964A5 (en:Method)
DE (1) DE2311570C2 (en:Method)
FR (1) FR2181807B1 (en:Method)
GB (1) GB1416872A (en:Method)
HK (1) HK10279A (en:Method)
KE (1) KE2916A (en:Method)
MY (1) MY7900137A (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA743270B (en) * 1973-06-15 1975-05-28 Upjohn Co Anti-hypertensive compounds
GB1474296A (en) * 1975-01-23 1977-05-18 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
JPS5717907Y2 (en:Method) * 1977-09-05 1982-04-14
GB1573186A (en) * 1977-09-14 1980-08-20 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
JPS6055170A (ja) * 1983-09-05 1985-03-30 株式会社多川工業 鉄骨切断装置
PH22302A (en) * 1985-02-11 1988-07-22 Fujisawa Pharmaceutical Co Piperidine compounds
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
ES2179071T3 (es) * 1993-04-07 2003-01-16 Otsuka Pharma Co Ltd Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada.
US5567718A (en) * 1994-08-11 1996-10-22 Hoechst Marion Roussel Inc. 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
AUPP818099A0 (en) * 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
MY142362A (en) 2004-01-29 2010-11-30 Otsuka Pharma Co Ltd Pharmaceutical composition for promoting angiogenesis
BRPI0709612A2 (pt) 2006-03-15 2011-07-19 Wyeth Corp composto de fórmula i; método para o tratamento de um distúrbio no sistema nervoso central relacionado ou afetado pelo receptor histamina-3 em um paciente que necessita deste tratamento; método para a inibição do receptor h3; composição farmacêutica; e processo para a preparação de um composto de fórmula i
PE20080371A1 (es) 2006-05-19 2008-04-09 Wyeth Corp N-benzoil-y-n-bencilpirrolidin-3-ilaminas como antagonistas de histamina-3
JP5164842B2 (ja) * 2006-07-28 2013-03-21 株式会社カネカ 光学活性３−アミノ含窒素化合物の製造法
PE20081152A1 (es) 2006-10-06 2008-08-10 Wyeth Corp Azaciclilaminas n-sustituidas como antagonistas de histamina-3
US7946311B2 (en) 2007-02-01 2011-05-24 Hobart Brorthers Company Robust preconditioned air hose
AR067549A1 (es) 2007-07-16 2009-10-14 Wyeth Corp Compuesto de oxazol,tiazol e imidazol, composicion farmaceutica que lo comprende , proceso para la preparacion del compuesto , uso del compuesto y metodos para la inhibicion del receptor h3 y para el tratamiento de un trastorno cognitivo relacionado con o afectado por el receptor de histamina -3 (h3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA731646A (en) * 1962-05-08 1966-04-05 Roussel-Uclaf 4-(2'(.beta.-MORPHOLYLETHOXYCARBONYL) PHENYLAMINE) 7-CHLORO QUINOLEINE ET SES SELS, AINSI QUE LEUR PROCEDE DE PREPARATION
BE754587A (fr) * 1969-08-08 1971-02-08 Upjohn Co Nouveaux p-(trihalomethylquinolylamino) benzamides et leur procede de preparation
BE754586A (fr) * 1969-08-08 1971-02-08 Upjohn Co Preparations pharmaceutiques a base de p-(4-quinolylamino) benzamide etleur utilisation

Also Published As

Publication number Publication date
AU5242173A (en) 1974-10-17
DE2311570C2 (de) 1986-03-13
BE855713Q (fr) 1977-10-03
KE2916A (en) 1979-03-30
DE2311570A1 (de) 1973-09-13
CH577476A5 (en:Method) 1976-07-15
FR2181807A1 (en:Method) 1973-12-07
AU467944B2 (en) 1975-12-18
CH576964A5 (en:Method) 1976-06-30
HK10279A (en) 1979-03-09
MY7900137A (en) 1979-12-31
FR2181807B1 (en:Method) 1976-10-22
JPS49273A (en:Method) 1974-01-05
GB1416872A (en) 1975-12-10

Similar Documents

Publication Publication Date Title
JPS604187B2 (ja) ４−アミノキノリン誘導体の製造方法
US3875165A (en) (4-Quinolylamino)-(N-piperidyl)benzamides and N-{8 (quinolylamino)-benzoyl{9 piperidines
US20060148815A1 (en) 4-Phenyl-1-piperazinyl, -piperidinyl and-tetrahydropyridyl derivatives
SK106395A3 (en) Treating and treatment or prevention of mental diseases
AU644296B2 (en) 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application
JP2005516898A (ja) Ｓｓｔ１アンタゴニスト活性を有するピペラジン誘導体
US4772614A (en) Quinolone sulphonamides useful as antihypertensive agents
US4243666A (en) 4-Amino-2-piperidino-quinazolines
JPH05194359A (ja) 新規尿素誘導体、その製法と治療用途
PT86082B (pt) Processo para a preparacao de agentes di-hidropiridinicos anti-alergicos e anti-inflamatorios
JPS58159459A (ja) １―フェニル―２―アミノカルボニルインドール化合物および該化合物を含有する抗不整脈剤
JPH0723365B2 (ja) フエノキシアルキルまたはチオフエノキシアルキル側鎖を有する新規ピペラジンカルボキシアミド化合物
JPH0579065B2 (en:Method)
EP0001175B1 (en) 4-aminoquinoline derivatives, a process for their preparation and pharmaceutical compositions containing them
CA1067080A (en) 2-(7-halo or trifluoromethyl-4-quinolylamino)-benzamide compounds
US4053615A (en) Phthalimidopiperidines and anti-convulsant compositions thereof
US3971789A (en) O-(4-Quinolylamino)benzamides
JPH0377867A (ja) 新規オキサゾロピリジン誘導体
US3647802A (en) 2-amino-4-aryl-3 4-dihydroquinolines
JP2006502989A5 (en:Method)
US3966761A (en) Novel amino-indazole compounds
CY1521A (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols,preparation and use thereof
JPH03188060A (ja) アニリン類及びベンジルアミン類から得られるベンジルセレノベンズアミド類、及びその製造方法
US3637846A (en) Carbostyril derivatives
US3706749A (en) N-acyl carbostyrils